EPA Begins TSCA Prioritization Process for Five Chemicals
The US Environmental Protection Agency (EPA) has announced that it is beginning the 12-month process to prioritize five additional chemicals for risk evaluation… read more
Latest News
New Publication Assessing Risk from Perfluorocarboxylic Acids in Fluorinated HDPE Containers
ToxStrategies scientists LeeAnn Racz, Alison Gauthier, Jennifer Bare, Melissa Heintz, David Feifarek, Stephanie Kennedy, and Julie Panko assessed the risk of human and… read more
ToxStrategies’ Scientists Publish Cobalt Bioavailability Comparison Study
ToxStrategies’ scientist Jennifer van de Ligt collaborated with a team of industry scientists to compare tissue cobalt concentrations and growth performance of beef… read more
HEORStrategies’ Dr. Naomi Sacks is a co-author on a large-scale study of obesity and overweight in the United States
Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study just published in the journal Obesity Science and Practice. Using national… read more
FDA Issues Updated Instructions for Serious Adverse Event Reporting for Cosmetic Products and Publishes Updated Structured Product Labeling (SPL)
On December 14, 2023, the U.S. Food and Drug Administration provided an update related to serious adverse event reporting mandated by the Modernization… read more
Dr. Daniele Wikoff has been appointed as new Chief Scientific Officer
ToxStrategies LLC is pleased to announce that Dr. Daniele Wikoff has been appointed as its new Chief Scientific Officer. Having had a key… read more
Case Study of In Silico Approach to Assessing Carcinogenicity
Two toxicologists from ToxStrategies’ Pharmaceuticals Practice are among the team with a new publication concerning the use of in silico (computer modeling) approaches… read more
Congressional Briefings on CBD Regulatory Status
ToxStrategies toxicologist Dr. Rayetta Henderson served on a panel that briefed both the U.S. House and Senate on the future regulation of CBD… read more